Improved Outcomes of Conduction System Pacing in Heart Failure with Reduced Ejection Fraction – A Systematic Review and Meta-analysis, by Geoff Wong and colleagues heartrhythmjournal.com/article/S1547-…
Gregg Fonarow MD Muthu Vaduganathan U.S. FDA Steve Greene Brendon Neuen @[email protected] Shelley Zieroth Alfonso Valle Ankeet S. Bhatt, MD, MBA Diego Segura-Rodriguez GoggleDocs Javed Butler JAMA Cardiology Dr. Deepak L. Bhatt Adrian “WE NEED RCTS!” Hernandez Clyde Yancy, MD, MSc John R Teerlink, MD HFSA JAMA Implementation is key now. We have the evidence that SGLT2i (or dual SGLT1/2i) work, now our patients have to receive it
Similar to MRA. We know spironolactone works in HFrEF but only 33% of patients were receiving it in the CHAMP-HF Jonathan Davis, MD, MPHS Steve Greene Harriette Van Spall, MD MPH
#moredataneeded !
HFrEF, mrEF, pEF - does EF still matter?
And especially what to do when LVEF returns to normal?
#GDMT : clear evidence for SGLT2i, but what about BB, MRA, RASi, Ivabradine, sGC-stimulators
#HeartFailure2023 #esc #HFA_ESC
Great to add to the growing literature & multiple late-breaking studies #HOTCRT by Pugal Vijayaraman on conducting system pacing at #HRS2023
More patient tailored resynchronization options the better for #HFREF
Alex Voskoboinik Chrishan Nalliah Dr. Jonathan Lipton Edward J Schloss MD Roderick Tung Weijian Huang
Carlos G Santos-Gallego, MD david leon jimenez Dr. Deepak L. Bhatt ChristosArgyropoulos MD, PhD FlozinatorInChief James Januzzi Jr MD Shelley Zieroth Harriette Van Spall, MD MPH Muthu Vaduganathan Anu Lala-Trindade Sumeet Singh Mitter, MD, MSc Pam R. Taub, MD❤️💃🏻 SGLT2inhibitor_lover Sanjay Kaul Andrew J Sauer MD Thanks Dr. Gallego! I like Farxiga, and have been prescribing it alot for HFpEF, HFrEF, CKD and DM2.
Risk of lack of initiation of GDMT in HFrEF, by drug class 👇
📚 courtesy of Gregg Fonarow MD and Steve Greene
#ACCFIT
Breaking news: FDA has just approved sotagliflozin (brand name 'Inpefa') for Treatment of Heart Failure!!!!
Broad label across full LVEF range (HFpEF&HFrEF), and for patients with or without T2DM
First dual SGLT1/2 inhibitor to be approved in HF
Dr. Deepak L. Bhatt ChristosArgyropoulos MD, PhD FlozinatorInChief
Enjoyed sharing our work studying the effects of pre-existing AF on outcomes in HFrEF and HFpEF patients at #ACC23 with Shari (Grossman) Kennedy Hanna Gaggin Mass General Heart MGH IM Residents
Which treatment sequence to use for HF ?
Animated discussion between clara saldarriaga & Milton Packer, enthusiastically hosted by Mewton Nathan 🤗
Watch their #HFASnacks
#HFA_ESC #HeartFailure2023
Thank you sir and bless you for your respect and caring!
Credit: ViralHog
🔸 For more inspiration and uplifting stories, please follow 👉 Epoch Inspired
#OnMyMind : New paradigms to address long-term exercise adherence, an Achilles heel of lifestyle interventions Anthony Peters Robert Mentz, MD Duke Clinical Research Institute Duke Heart #AHAJournals ahajournals.org/doi/10.1161/CI…
Recording #HFAsnacks2023 at #HeartFailure2023 with the great Milton Packer & clara saldarriaga on how to implement HFrEF quadritherapy ! 🤩🤩🤩🤩
James Januzzi Jr MD HFAPresident Wilfried Mullens Shelley Wood (she/her) Nicolas Girerd Laura Meems
Interesting discussion on HFREF treatment implementation during #HeartFailure2023 #Cardiology meeting ! With two exciting stars ⭐️ Miltonpacker & clara saldarriaga ! Share and check it out ! Théo Pezel Pr D ANGOULVANT Stephan Achenbach Javed Butler
Exercise training in Heart failure with Preserved and Reduced Ejection Fraction: A Systematic Review and Meta-Analysis by Jamie Edwards and Dr Jamie O'Driscoll 🏃♂️💪🏌️♂️🚴♂️🚣♂️🏋️♂️
📌⏫exercise capacity⏫quality of life 👥 HFpEF/HFrEF.
📌👥HFpEF⏬E/e*
📌👥HFrEF ⏬BNP/NTproBNP
📌↔️🏥⚰️
🚨 #SimPub #HeartFailure2023 now in JAMA Cardiology
Eligible 🇺🇸 pts hospitalized for #HFrEF ...
⚠️Only 1 in 5 discharged on #SGLT2i
⚠️<1 in 10 on #quadtherapy
⬆️⬆️ variation in use by🏥 (some high, some ZERO)
We must overcome implementation barriers
jamanetwork.com/journals/jamac…